Why India needs to regulate Ayurveda to win the world market for natural remedies – ThePrint

Illustration by Ramandeep Kaur
Illustration by Ramandeep Kaur | ThePrint

Text Size:

The ‘Coronil’ controversy last month highlighted the problems with regulating Ayurveda in India. Patanjali claimed to have developed an Ayurvedic medicine that would protect people from Covid-19 and also cure the disease. Later revelations raised doubts about these claims and the process of testing these medicines.

The episode highlighted how modern thinking is creeping into alternative medicine. This is good, and India stands to gain enormously as a producer and exporter of traditional herbal medicines.

The world’s growing fascination with natural remedies, traditional and alternative medicines and herbs augurs well for India. These can provide a substantial source of income for farmers and companies across the country.

Traditional medicines have been used in India, even though there is little quality control or trials. A very small quantity of herbal medicines produced in India is exported, as they do not meet the regulatory standards required by importing countries. While they can be a great source of income and exports for India, we will need a modern regulatory system to succeed.

Even at its current levels, with little exports, estimates are that Ayurveda is a Rs 30,000 crore industry in India.


Also read: Ayurveda, FMCG, Covid, controversy — Baba Ramdev and the Patanjali school of marketing

We are deeply grateful to our readers & viewers for their time, trust and subscriptions.

Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrint’s future.

SUBSCRIBE NOW